EARLY DETECTION AND DIAGNOSTIC STRATEGIES FOR BENIGN TUMORS AND PRECANCEROUS CONDITIONS OF THE MAXILLOFACIAL AND NECK REGION
Keywords:
maxillofacial tumors, precancerous lesions, early diagnosis, oral pathology, benign neoplasms, cervical tumors, oncological vigilance, leukoplakia, erythroplakia.Abstract
Early identification of pathological processes within the maxillofacial and cervical regions is an essential component of modern preventive medicine and oncological vigilance. Benign tumors and precancerous lesions occurring in the face, jaw, and neck areas represent a significant clinical challenge because of their potential for malignant transformation, functional impairment, and aesthetic consequences. The anatomical complexity of these regions, combined with the diversity of epithelial, connective tissue, vascular, and neural structures, contributes to a wide spectrum of pathological formations. Although benign neoplasms are generally characterized by slow growth and limited invasiveness, delayed diagnosis may lead to progressive tissue destruction or increase the risk of malignant transformation. Global epidemiological data indicate that approximately 5–10% of oral and maxillofacial lesions diagnosed in clinical practice are precancerous conditions. Among these, leukoplakia, erythroplakia, oral submucous fibrosis, and certain benign epithelial proliferations demonstrate the highest potential for malignant change. According to international oncological statistics, the annual incidence of oral and maxillofacial malignancies exceeds 350,000 cases worldwide, with a considerable proportion developing from previously undiagnosed or inadequately monitored premalignant lesions. Modern diagnostic strategies emphasize early screening, risk assessment, and multidisciplinary evaluation involving dental surgeons, oncologists, and maxillofacial specialists. Clinical examination, imaging technologies, histopathological verification, and molecular diagnostic methods play a crucial role in identifying early pathological changes before the development of invasive carcinoma. Advances in digital imaging, biomarker detection, and minimally invasive biopsy techniques have significantly improved diagnostic accuracy.
References
1. Neville, B. W., Damm, D. D., Allen, C. M., & Chi, A. C. (2016). Oral and maxillofacial pathology (4th ed.). Elsevier.
2. Warnakulasuriya, S., Johnson, N. W., & Van der Waal, I. (2007). Nomenclature and classification of potentially malignant disorders of the oral mucosa. Journal of Oral Pathology & Medicine, 36(10), 575–580.
3. Regezi, J. A., Sciubba, J. J., & Jordan, R. C. K. (2017). Oral pathology: Clinical pathologic correlations (7th ed.). Elsevier.
4. Kumar, V., Abbas, A. K., & Aster, J. C. (2020). Robbins and Cotran pathologic basis of disease (10th ed.). Elsevier.
5. Petersen, P. E. (2009). Oral cancer prevention and control. Oral Oncology, 45(4–5), 454–460.
6. Scully, C., & Porter, S. (2008). Oral cancer. BMJ, 336(7649), 830–833.
7. Speight, P. M., & Farthing, P. M. (2018). The pathology of oral cancer. British Dental Journal, 225(9), 841–847.
8. Warnakulasuriya, S. (2018). Clinical features and presentation of oral potentially malignant disorders. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 125(6), 582–590.
9. Rivera, C. (2015). Essentials of oral cancer. International Journal of Clinical and Experimental Pathology, 8(9), 11884–11894.
10. Thomson, P. J. (2012). Perspectives on oral squamous cell carcinoma prevention. Head & Neck Oncology, 4(1), 1–9.
11. Chi, A. C., Day, T. A., & Neville, B. W. (2015). Oral cavity and oropharyngeal squamous cell carcinoma. CA: A Cancer Journal for Clinicians, 65(5), 401–421.
12. Lingen, M. W., Kalmar, J. R., Karrison, T., & Speight, P. M. (2008). Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncology, 44(1), 10–22.
13. Sankaranarayanan, R., Ramadas, K., & Thomas, G. (2013). Oral cancer screening. Oral Oncology, 49(4), 314–320.
14. Gupta, B., & Johnson, N. W. (2014). Systematic review of oral cancer risk factors. Oral Oncology, 50(5), 364–374.
15. Mehanna, H., Paleri, V., West, C. M., & Nutting, C. (2010). Head and neck cancer. BMJ, 341, c4684.
16. Gorsky, M., Epstein, J. B., & Oakley, C. (2004). Carcinoma arising from oral leukoplakia. Oral Surgery, Oral Medicine, Oral Pathology, 98(3), 274–281.
17. Sciubba, J. J. (2001). Oral cancer: The importance of early diagnosis. Journal of the American Dental Association, 132, 12S–18S.
18. van der Waal, I. (2009). Potentially malignant disorders of the oral mucosa. Oral Oncology, 45(4–5), 317–323.
19. Reichart, P. A., & Philipsen, H. P. (2005). Oral erythroplakia. Oral Oncology, 41(6), 551–561.
20. Petersen, P. E., Bourgeois, D., Ogawa, H., Estupinan-Day, S., & Ndiaye, C. (2005). Global burden of oral diseases. Community Dentistry and Oral Epidemiology, 33(6), 397–409.
